Erratum: Wise regulates bone deposition through genetic interactions with Lrp5 (PLoS ONE (2014) 9, 5 (e96257) DOI: 10.1371/journal.pone.0096257);Wise regulates bone deposition through genetic interactions with Lrp5

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Ellies, Debra L ^a,e,f   Economou, Androulla ^b   Viviano, Beth ^c   Rey, Jean Philippe ^a   Paine Saunders, Stephenie ^c   Krumlauf, Robb ^a,b,d   Saunders, Scott ^c  

^a STOWERS INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^e OsteoGeneX Inc   (United States)

^f UNIVERSITY OF KANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; SCLEROSTIN; WNT PROTEIN; BONE MORPHOGENETIC PROTEIN; GLYCOPROTEIN; LRP5 PROTEIN, MOUSE; SOST PROTEIN, MOUSE; SOSTDC1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE DEVELOPMENT; BONE MASS; CARTILAGE CELL; CELL PROLIFERATION; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENE INSERTION; GENE INTERACTION; GENE MUTATION; GENETIC REGULATION; LRP5 GENE; MOUSE; NONHUMAN; OSTEOBLAST; PHENOTYPE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WISE GENE; ANIMAL; ANIMAL EMBRYO; C57BL MOUSE; EMBRYOLOGY; FEMALE; FEMUR; GENETICS; MALE; METABOLISM; MUTATION; NEWBORN; WNT SIGNALING PATHWAY;

ANIMALS; ANIMALS, NEWBORN; BONE DENSITY; BONE MORPHOGENETIC PROTEINS; CELL PROLIFERATION; CHONDROCYTES; EMBRYO, MAMMALIAN; FEMALE; FEMUR; GLYCOPROTEINS; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-5; MALE; MICE; MICE, INBRED C57BL; MUTATION; OSTEOBLASTS; OSTEOGENESIS; WNT SIGNALING PATHWAY;

EID: 84900314524     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104467     Document Type: Erratum

References (44)

1. Day TF, Guo X, Garrett-Beal L, Yang Y (2005) Wnt/beta-Catenin Signaling in Mesenchymal Progenitors Controls Osteoblast and Chondrocyte Differentiation during Vertebrate Skeletogenesis. Dev Cell 8: 739-750. (Pubitemid 40585296)
2. Glass DA 2nd, Bialek P, Ahn JD, Starbuck M, Patel MS, et al. (2005) Canonical wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 8: 751-764. (Pubitemid 40585297)
3. Hill TP, Spater D, Taketo MM, Birchmeier W, Hartmann C (2005) Canonical Wnt/beta-Catenin Signaling Prevents Osteoblasts from Differentiating into Chondrocytes. Dev Cell 8: 727-738. (Pubitemid 40585295)
4. Holmen SL, Zylstra CR, Mukherjee A, Sigler RE, Faugere MC, et al. (2005) Essential role of beta -catenin in post natal bone acquisition. J Biol Chem 280: 21162-21168. (Pubitemid 40805677)
5. Zhong N, Gersch RP, Hadjiargyrou M (2006) Wnt signaling activation during bone regeneration and the role of Dishevelled in chondrocyte proliferation and differentiation. Bone 39: 5-16. (Pubitemid 43831768)
6. Kato M, Patel MS, Levasseur R, Lobov I, Chang BH, et al. (2002) Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol 157: 303-314. (Pubitemid 34839826)
7. Babij P, Zhao W, Small C, Kharode Y, Yaworsky PJ, et al. (2003) High bone mass in mice expressing a mutant LRP5 gene. J Bone Miner Res 18: 960-974. (Pubitemid 37294932)
8. Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, et al. (2002) High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 346: 1513-1521. (Pubitemid 34755690)
9. Fujino T, Asaba H, Kang MJ, Ikeda Y, Sone H, et al. (2003) Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion. Proceedings of the National Academy of Sciences of the United States of America 100: 229-234. (Pubitemid 36078057)
10. Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, et al. (2001) LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107: 513-523. (Pubitemid 33152786)
11. Little RD, Carulli JP, Del Mastro RG, Dupuis J, Osborne M, et al. (2002) A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. American Journal of Human Genetics 70: 11-19. (Pubitemid 34031693)
12. Patel MS, Karsenty G (2002) Regulation of bone formation and vision by LRP5. N Engl J Med 346: 1572-1574. (Pubitemid 34755698)
13. Balemans W, Devogelaer JP, Cleiren E, Piters E, Caussin E, et al. (2007) Novel LRP5 missense mutation in a patient with a high bone mass phenotype results in decreased DKK1-mediated inhibition of Wnt signaling. J Bone Miner Res 22: 708-716. (Pubitemid 351339099)
14. Bhat BM, Allen KM, Liu W, Graham J, Morales A, et al. (2007) Structure-based mutation analysis shows the importance of LRP5 beta-propeller 1 in modulating Dkk1-mediated inhibition of Wnt signaling. Gene 391: 103-112. (Pubitemid 46356790)
15. Rickels MR, Zhang X, Mumm S, Whyte MP (2005) Oropharyngeal skeletal disease accompanying high bone mass and novel LRP5 mutation. J Bone Miner Res 20: 878-885. (Pubitemid 40571645)
16. Van Wesenbeeck L, Cleiren E, Gram J, Beals RK, Benichou O, et al. (2003) Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density. Am J Hum Genet 72: 763-771. (Pubitemid 36255977)
17. Yadav VK, Ryu JH, Suda N, Tanaka KF, Gingrich JA, et al. (2008) Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell 135: 825-837.
18. Cui Y, Niziolek PJ, MacDonald BT, Zylstra CR, Alenina N, et al. (2011) Lrp5 functions in bone to regulate bone mass. Nature Medicine 17: 684-691.
19. Itasaki N, Jones CM, Mercurio S, Rowe A, Domingos PM, et al. (2003) Wise, a context-dependent activator and inhibitor of Wnt signalling. Development 130: 4295-4305. (Pubitemid 37185319)
20. Ellies DL, Viviano B, McCarthy J, Rey JP, Itasaki N, et al. (2006) Bone density ligand, Sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 21: 1738-1749.
21. Laurikkala J, Kassai Y, Pakkasjarvi L, Thesleff I, Itoh N (2003) Identification of a secreted BMP antagonist, ectodin, integrating BMP, FGF, and SHH signals from the tooth enamel knot. Developmental Biology 264: 91-105. (Pubitemid 37393449)
22. Yanagita M, Oka M, Watabe T, Iguchi H, Niida A, et al. (2004) USAG-1: a bone morphogenetic protein antagonist abundantly expressed in the kidney. Biochemical and Biophysical Research Communications 316: 490-500. (Pubitemid 38338618)
23. Semenov M, Tamai K, He X (2005) SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor. The Journal of biological chemistry 280: 26770-26775. (Pubitemid 41040710)
24. Beighton P, Davidson J, Durr L, Hamersma H (1977) Sclerosteosis - an autosomal recessive disorder. Clinical Genetics 11: 1-7.
25. Brunkow ME, Gardner JC, Van Ness J, Paeper BW, Kovacevich BR, et al. (2001) Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. American Journal of Human Genetics 68: 577-589. (Pubitemid 32202753)
26. Balemans W, Ebeling M, Patel N, Van Hul E, Olson P, et al. (2001) Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet 10: 537-543. (Pubitemid 32184286)
27. Kusu N, Laurikkala J, Imanishi M, Usui H, Konishi M, et al. (2003) Sclerostin is a novel secreted osteoclast-derived bone morphogenetic protein antagonist with unique ligand specificity. The Journal of biological chemistry 278: 24113-24117. (Pubitemid 36830246)
28. Winkler DG, Sutherland MK, Geoghegan JC, Yu C, Hayes T, et al. (2003) Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. The EMBO journal 22: 6267-6276. (Pubitemid 37522584)
29. Li X, Zhang Y, Kang H, Liu W, Liu P, et al. (2005) Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. The Journal of biological chemistry 280: 19883-19887. (Pubitemid 41379516)
30. Ahn Y, Sanderson BW, Klein OD, Krumlauf R (2010) Inhibition of Wnt signaling by Wise (Sostdc1) and negative feedback from Shh controls tooth number and patterning. Development 137: 3221-3231.
31. Ahn Y, Sims C, Logue JM, Weatherbee SD, Krumlauf R (2013) Lrp4 and Wise interplay controls the formation and patterning of mammary and other skin appendage placodes by modulating Wnt signaling. Development 140: 583-593.
32. Collette NM, Yee CS, Murugesh D, Sebastian A, Taher L, et al. (2013) Sost and its paralog Sostdc1 coordinate digit number in a Gli3-dependent manner. Developmental Biology.
33. Beamer WG, Donahue LR, Rosen CJ, Baylink DJ (1996) Genetic variability in adult bone density among inbred strains of mice. Bone 18: 397-403. (Pubitemid 26152301)
34. Kokubu C, Heinzmann U, Kokubu T, Sakai N, Kubota T, et al. (2004) Skeletal defects in ringelschwanz mutant mice reveal that Lrp6 is required for proper somitogenesis and osteogenesis. Development 131: 5469-5480. (Pubitemid 39562189)
35. Holmen SL, Giambernardi TA, Zylstra CR, Buckner-Berghuis BD, Resau JH, et al. (2004) Decreased BMD and limb deformities in mice carrying mutations in both Lrp5 and Lrp6. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 19: 2033-2040.
36. Kelly OG, Pinson KI, Skarnes WC (2004) The Wnt co-receptors Lrp5 and Lrp6 are essential for gastrulation in mice. Development 131: 2803-2815. (Pubitemid 39004073)
37. Stein SA, Witkop C, Hill S, Fallon MD, Viernstein L, et al. (1983) Sclerosteosis: neurogenetic and pathophysiologic analysis of an American kinship. Neurology 33: 267-277. (Pubitemid 13155755)
38. Yu HM, Jerchow B, Sheu TJ, Liu B, Costantini F, et al. (2005) The role of Axin2 in calvarial morphogenesis and craniosynostosis. Development 132: 1995-2005. (Pubitemid 40691787)
39. Hartmann C (2006) A Wnt canon orchestrating osteoblastogenesis. Trends in Cell Biology 16: 151-158.
40. Rodda SJ, McMahon AP (2006) Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development 133: 3231-3244. (Pubitemid 44404346)
41. Zhang M, Yan Y, Lim YB, Tang D, Xie R, et al. (2009) BMP-2 modulates beta-catenin signaling through stimulation of Lrp5 expression and inhibition of beta-TrCP expression in osteoblasts. J Cell Biochem 108: 896-905.
42. Leupin O, Piters E, Halleux C, Hu S, Kramer I, et al. (2011) Bone overgrowth-associated mutations in the LRP4 gene impair sclerostin facilitator function. J Biol Chem 286: 19489-19500.
43. Latinkic BV, Mercurio S, Bennett B, Hirst EM, Xu Q, et al. (2003) Xenopus Cyr61 regulates gastrulation movements and modulates Wnt signalling. Development 130: 2429-2441. (Pubitemid 36722394)
44. Mercurio S, Latinkic B, Itasaki N, Krumlauf R, Smith JC (2004) Connective-tissue growth factor modulates WNT signalling and interacts with the WNT receptor complex. Development 131: 2137-2147. (Pubitemid 38702045)